Incident Type 2 Diabetes in OSA and Effect of CPAP Treatment

A Retrospective Clinic Cohort Study


      The relationship between OSA and glucose metabolism remains controversial. This retrospective study investigated the relationship between OSA and incident type 2 diabetes (T2D) in a clinic cohort of Chinese adults in Hong Kong, and the effect of long-term CPAP treatment.


      Data for diagnosis of incident T2D and CPAP usage were obtained from the territory-wide electronic health administration system and records of protocolized evaluation of CPAP adherence at the sleep clinic. The relationship between baseline OSA and incident T2D and the effect of CPAP therapy were examined by Cox regression models. Risk of incident T2D over the continuum of apnea-hypopnea index was examined with cubic spline analysis.


      Of 1,206 subjects with overnight sleep studies and clinical assessment in 2006 through 2013, 152 developed diabetes (median follow-up, 7.3 years). In fully adjusted models, patients with untreated moderate or severe OSA had higher risk of developing diabetes, hazard ratios 2.01 (95% CI, 1.06-3.81) and 2.62 (95% CI, 1.40-4.93) respectively, with a trend to plateau in those with severe OSA. No interaction was demonstrated between OSA and obesity. Regular CPAP use, which was attained in about one-third of subjects with moderate-severe OSA, was associated with reduction of diabetes incidence from 3.41 to 1.61 per 100 person-years, and of adjusted hazard risk to that of non-OSA.


      OSA severity independently predicted incident diabetes. Regular long-term CPAP use was associated with reduced risk of incident T2D, after adjustment for various baseline metabolic risk factors and subsequent body weight change.

      Key Words


      AASM (American Academy of Sleep Medicine), HR (hazard ratio), ODI (oxygen desaturation index), PSG (polysomnography), RCT (randomized controlled trial), T2D (type 2 diabetes)
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Senaratna C.V.
        • Perret J.L.
        • Lodge C.J.
        • et al.
        Prevalence of obstructive sleep apnea in the general population: a systematic review.
        Sleep Med Rev. 2017; 34: 70-81
        • World Health Organization
        Global report on diabetes.
        World Health Organization, 2016
        • Shaw J.E.
        • Punjabi N.M.
        • Wilding J.P.
        • Alberti K.G.
        • Zimmet P.Z.
        Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention.
        Diabetes Res Clin Pract. 2008; 81: 2-12
        • Reutrakul S.
        • Mokhlesi B.
        Obstructive sleep apnea and diabetes: a state of the art review.
        Chest. 2017; 152: 1070-1086
        • Chen L.
        • Kuang J.
        • Pei J.H.
        • et al.
        Continuous positive airway pressure and diabetes risk in sleep apnea patients: a systemic review and meta-analysis.
        Eur J Intern Med. 2017; 39: 39-50
      1. Abud R, Salgueiro M, Drake L, Reyes T, Jorquera J, Labarc G. Efficacy of continuous positive airway pressure (CPAP) preventing type 2 diabetes mellitus in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and insulin resistance: a systematic review and meta-analysis. Sleep Med. In press.

        • Hoyos C.M.
        • Drager L.F.
        • Patel S.R.
        OSA and cardiometabolic risk: what's the bottom line?.
        Respirology. 2017; 22: 420-429
        • Martinez-Garcia M.A.
        • Campos-Rodriguez F.
        • Javaheri S.
        • Gozal D.
        Pro: continuous positive airway pressure and cardiovascular prevention.
        Eur Respir J. 2018; 51 (1702400.)
        • Botros N.
        • Concato J.
        • Mohsenin V.
        • Selim B.
        • Doctor K.
        • Yaggi H.K.
        Obstructive sleep apnea as a risk factor for type 2 diabetes.
        Am J Med. 2009; 122: 1122-1127
        • Kendzerska T.
        • Gershon A.S.
        • Hawker G.
        • Tomlinson G.
        • Leung R.S.
        Obstructive sleep apnea and incident diabetes. A historical cohort study.
        Am J Respir Crit Care Med. 2014; 190: 218-225
        • Iber C.
        • Ancoli-Israel S.
        • Chesson Jr., A.L.
        • et al.
        The AASM Manual for the Scoring of Sleep and Associated Events: Rules Terminology and Technical Specifications.
        American Academy of Sleep Medicine, Westchester, IL2007
        • Berry R.B.
        • Brooks R.
        • Gamaldo C.E.
        • Harding S.M.
        • Marcus C.L.
        • Vaughn B.V.
        The AASM Manual for the Scoring of Sleep and Associated Events. Rules, Terminology and Technical Specifications.
        American Academy of Sleep Medicine, Darien, IL2012
        • Kushida C.A.
        • Littner M.R.
        • Hirshkowitz M.
        • et al.
        Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders.
        Sleep. 2006; 29: 375-380
        • American Diabetes Association
        Standards of Medical Care in Diabetes—2015.
        Diabetes Care. 2015; 38: S8-S16
        • Johns M.W.
        A new method for measuring daytime sleepiness: the Epworth sleepiness scale.
        Sleep. 1991; 14: 540-545
        • Desquilbet L.
        • Mariotti F.
        Dose-response analyses using restricted cubic spline functions in public health research.
        Stat Med. 2010; 29: 1037-1057
        • Knol M.J.
        • VanderWeele T.J.
        Recommendations for presenting analyses of effect modification and interaction.
        Int J Epidemiol. 2012; 41: 514-520
        • World Health Organization. Regional Office for the Western Pacific
        The Asia-Pacific perspective: redefining obesity and its treatment.
        Health Communications Australia, Sydney2000 (
        • Grimaldi D.
        • Beccuti G.
        • Touma C.
        • Van Cauter E.
        • Mokhlesi B.
        Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications.
        Diabetes Care. 2014; 37: 355-363
        • Ip M.S.
        • Lam B.
        • Ng M.M.
        • Lam W.K.
        • Tsang K.W.
        • Lam K.S.
        Obstructive sleep apnea is independently associated with insulin resistance.
        Am J Respir Crit Care Med. 2002; 165: 670-676
        • Boyko E.J.
        • Seelig A.D.
        • Jacobson I.G.
        • et al.
        Sleep characteristics, mental health, and diabetes risk: a prospective study of U.S. military service members in the Millennium Cohort Study.
        Diabetes Care. 2013; 36: 3154-3161
        • Muraki I.
        • Tanigawa T.
        • Yamagishi K.
        • et al.
        Nocturnal intermittent hypoxia and metabolic syndrome; the effect of being overweight: the CIRCS study.
        J Atheroscler Thromb. 2010; 17: 369-377
        • Quan J.
        • Li T.K.
        • Pang H.
        • et al.
        Diabetes incidence and prevalence in Hong Kong, China during 2006-2014.
        Diabetic Med. 2017; 34: 902-908
        • Ip M.S.
        • Lam B.
        • Lauder I.J.
        • et al.
        A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong.
        Chest. 2001; 119: 62-69
        • Ip M.S.
        • Lam B.
        • Tang L.C.
        • Lauder I.J.
        • Ip T.Y.
        • Lam W.K.
        A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong: prevalence and gender differences.
        Chest. 2004; 125: 127-134
        • Kent B.D.
        • Grote L.
        • Bonsignore M.R.
        • et al.
        Sleep apnoea severity independently predicts glycaemic health in nondiabetic subjects: the ESADA study.
        Eur Respir J. 2014; 44: 130-139
        • Aronsohn R.S.
        • Whitmore H.
        • Van Cauter E.
        • Tasali E.
        Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes.
        Am J Respir Crit Care Med. 2010; 181: 507-513
        • Muraki I.
        • Tanigawa T.
        • Yamagishi K.
        • et al.
        Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS).
        Diabetologia. 2010; 53: 481-488
        • Chirinos J.A.
        • Gurubhagavatula I.
        • Teff K.
        • et al.
        CPAP, weight loss, or both for obstructive sleep apnea.
        N Engl J Med. 2014; 370: 2265-2275
        • Hudgel D.W.
        Sleep apnea severity classification – revisited.
        Sleep. 2016; 39: 1165-1166
        • Randerath W.
        • Bassetti C.L.
        • Bonsignore M.R.
        • et al.
        Challenges and perspectives in obstructive sleep apnoea.
        Eur Respir J. 2018; 52: 1702616
        • Newhouse L.P.
        • Joyner M.J.
        • Curry T.B.
        • et al.
        Three hours of intermittent hypoxia increases circulating glucose levels in healthy adults.
        Physiol Rep. 2017; 5
        • Jun J.C.
        • Shin M.K.
        • Devera R.
        • et al.
        Intermittent hypoxia-induced glucose intolerance is abolished by alpha-adrenergic blockade or adrenal medullectomy.
        Am J Physiol Endocrinol Metab. 2014; 307: E1073-E1083
        • Ryan S.
        Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction.
        J Physiol. 2017; 595: 2423-2430
        • Weiszenstein M.
        • Shimoda L.A.
        • Koc M.
        • Seda O.
        • Polak J.
        Inhibition of lipolysis ameliorates diabetic phenotype in a mouse model of obstructive sleep apnea.
        Am J Respir Cell Mol Biol. 2016; 55: 299-307
        • Thomas A.
        • Belaidi E.
        • Moulin S.
        • et al.
        Chronic intermittent hypoxia impairs insulin sensitivity but improves whole-body glucose tolerance by activating skeletal muscle AMPK.
        Diabetes. 2017; 66: 2942-2951
        • Jullian-Desayes I.
        • Joyeux-Faure M.
        • Tamisier R.
        • et al.
        Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials.
        Sleep Med Rev. 2015; 21: 23-38
        • Mokhlesi B.
        • Grimaldi D.
        • Beccuti G.
        • Van Cauter E.
        Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes.
        Diabetes Obes Metab. 2017; 19: 452-456
        • Chopra S.
        • Rathore A.
        • Younas H.
        • et al.
        Obstructive sleep apnea dynamically increases nocturnal plasma free fatty acids, glucose, and cortisol during sleep.
        J Clin Endocrinol Metab. 2017; 102: 3172-3181
        • Ioachimescu O.C.
        • Anthony Jr., J.
        • Constantin T.
        • Ciavatta M.M.
        • McCarver K.
        • Sweeney M.E.
        VAMONOS (Veterans Affairs' Metabolism, Obstructed and Non-Obstructed Sleep) Study. Effects of CPAP therapy on glucose metabolism in patients with obstructive sleep apnea.
        J Clin Sleep Med. 2017; 13: 455-466
        • Bakker J.P.
        • Weaver T.E.
        • Parthasarathy S.
        • Aloia M.S.
        Adherence to CPAP: what should we be aiming for, and how can we get there?.
        Chest. 2019; 155: 1272-1287